MWVC
IBB icon

Morgens Waterfall Vintiadis & Co’s iShares Biotechnology ETF IBB Stock Holding History

Morgens Waterfall Vintiadis & Co’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-13,500
Closed -$1.5M – 66
2017
Q3 		$1.5M Buy
13,500
+7,500
+125% +$802K 1.26% 29
2017
Q2 		$620K Buy
+6,000
New +$591K 0.6% 44

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgens Waterfall Vintiadis & Co's IBB Position: Q4 2017 in Review

Morgens Waterfall Vintiadis & Co sold out of iShares Biotechnology ETF (IBB) in Q4 2017, closing a stake of 13,500 shares — an estimated $1.5M sold.

Morgens Waterfall Vintiadis & Co first reported a position in IBB in Q2 2017 and held it in 2 quarters. The position peaked at $1.5M in Q3 2017. 624 funds tracked by Wall St. Rank hold IBB as of Q4 2017.

  • Morgens Waterfall Vintiadis & Co reported no remaining iShares Biotechnology ETF position as of Q4 2017 after selling out during the quarter.
  • Morgens Waterfall Vintiadis & Co sold 13,500 iShares Biotechnology ETF shares in Q4 2017, an estimated $1.5M.
  • Morgens Waterfall Vintiadis & Co first reported a position in iShares Biotechnology ETF in Q2 2017 and held it in 2 quarters.
  • Morgens Waterfall Vintiadis & Co's iShares Biotechnology ETF position peaked at $1.5M in Q3 2017.
  • 624 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2017.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q4 2017, filed 14 Feb 2018.